Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog

Objective Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other than obesity are more substantial predictors of insulin sensitivity under baseline, nonstimulated conditions....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity (Silver Spring, Md.) Md.), 2014-05, Vol.22 (5), p.1238-1245
Hauptverfasser: Ader, Marilyn, Stefanovski, Darko, Kim, Stella P., Richey, Joyce M., Ionut, Viorica, Catalano, Karyn J., Hucking, Katrin, Ellmerer, Martin, Citters, Gregg, Hsu, Isabel R., Chiu, Jenny D., Woolcott, Orison O., Harrison, Lisa N., Zheng, Dan, Lottati, Maya, Kolka, Cathryn M., Mooradian, Vahe, Dittmann, Justin, Yae, Sophia, Liu, Huiwen, Castro, Ana Valeria B., Kabir, Morvarid, Bergman, Richard N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1245
container_issue 5
container_start_page 1238
container_title Obesity (Silver Spring, Md.)
container_volume 22
creator Ader, Marilyn
Stefanovski, Darko
Kim, Stella P.
Richey, Joyce M.
Ionut, Viorica
Catalano, Karyn J.
Hucking, Katrin
Ellmerer, Martin
Citters, Gregg
Hsu, Isabel R.
Chiu, Jenny D.
Woolcott, Orison O.
Harrison, Lisa N.
Zheng, Dan
Lottati, Maya
Kolka, Cathryn M.
Mooradian, Vahe
Dittmann, Justin
Yae, Sophia
Liu, Huiwen
Castro, Ana Valeria B.
Kabir, Morvarid
Bergman, Richard N.
description Objective Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other than obesity are more substantial predictors of insulin sensitivity under baseline, nonstimulated conditions. Methods Metabolic assessment was performed in healthy dogs (n = 90). Whole‐body sensitivity from euglycemic clamps (SICLAMP) was the primary outcome variable, and was measured independently by IVGTT (n = 36). Adiposity was measured by MRI (n = 90), and glucose‐stimulated insulin response was measured from hyperglycemic clamp or IVGTT (n = 86 and 36, respectively). Results SICLAMP was highly variable (5.9‐75.9 dl/min per kg per μU/ml). Despite narrow range of body weight (mean, 28.7 ± 0.3 kg), adiposity varied approximately eight‐fold and was inversely correlated with SICLAMP (P 
doi_str_mv 10.1002/oby.20625
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1521339014</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1521339014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4545-7e81ee58a23a42b044e94d7a8a065cb7f883f815f8b174a8d74fda27739f7f583</originalsourceid><addsrcrecordid>eNp1kEFLwzAUx4MoTqcHv4AUvOhhW5ImTXrUoU4Y7KKgBwlp-6IZbTqTVum3t25zB8HTezx-7897P4TOCB4TjOmkzroxxQnle-iIpDEeiTh93t_1kgzQcQhLjFmCOTlEA8oIjdNEHKHXGax0Y_PIutCW1kV5Cdprl0NkQ9S8Q7TyttK-iwpowFfWaddEtdnxAVywjf20TdfP1huu9pUuo6J-O0EHRpcBTrd1iJ7ubh-ns9F8cf8wvZ6PcsYZHwmQBIBLTWPNaIYZg5QVQkuNE55nwkgZG0m4kRkRTMtCMFNoKvo3jTBcxkN0ucld-fqjhdCoyoYcylI7qNugCKckjlNMWI9e_EGXdetdf50iieAkpbhnh-hqQ-W-DsGDUVsNimD141z1ztXaec-ebxPbrIJiR_5K7oHJBviyJXT_J6nFzcsm8huKdIr5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1675192021</pqid></control><display><type>article</type><title>Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog</title><source>MEDLINE</source><source>Wiley Free Content</source><source>Wiley Online Library All Journals</source><creator>Ader, Marilyn ; Stefanovski, Darko ; Kim, Stella P. ; Richey, Joyce M. ; Ionut, Viorica ; Catalano, Karyn J. ; Hucking, Katrin ; Ellmerer, Martin ; Citters, Gregg ; Hsu, Isabel R. ; Chiu, Jenny D. ; Woolcott, Orison O. ; Harrison, Lisa N. ; Zheng, Dan ; Lottati, Maya ; Kolka, Cathryn M. ; Mooradian, Vahe ; Dittmann, Justin ; Yae, Sophia ; Liu, Huiwen ; Castro, Ana Valeria B. ; Kabir, Morvarid ; Bergman, Richard N.</creator><creatorcontrib>Ader, Marilyn ; Stefanovski, Darko ; Kim, Stella P. ; Richey, Joyce M. ; Ionut, Viorica ; Catalano, Karyn J. ; Hucking, Katrin ; Ellmerer, Martin ; Citters, Gregg ; Hsu, Isabel R. ; Chiu, Jenny D. ; Woolcott, Orison O. ; Harrison, Lisa N. ; Zheng, Dan ; Lottati, Maya ; Kolka, Cathryn M. ; Mooradian, Vahe ; Dittmann, Justin ; Yae, Sophia ; Liu, Huiwen ; Castro, Ana Valeria B. ; Kabir, Morvarid ; Bergman, Richard N.</creatorcontrib><description>Objective Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other than obesity are more substantial predictors of insulin sensitivity under baseline, nonstimulated conditions. Methods Metabolic assessment was performed in healthy dogs (n = 90). Whole‐body sensitivity from euglycemic clamps (SICLAMP) was the primary outcome variable, and was measured independently by IVGTT (n = 36). Adiposity was measured by MRI (n = 90), and glucose‐stimulated insulin response was measured from hyperglycemic clamp or IVGTT (n = 86 and 36, respectively). Results SICLAMP was highly variable (5.9‐75.9 dl/min per kg per μU/ml). Despite narrow range of body weight (mean, 28.7 ± 0.3 kg), adiposity varied approximately eight‐fold and was inversely correlated with SICLAMP (P &lt; 0.025). SICLAMP was negatively associated with fasting insulin, but most strongly associated with insulin clearance. Clearance was the dominant factor associated with sensitivity (r = 0.53, P &lt; 0.00001), whether calculated from clamp or IVGTT. Conclusions These data suggest that insulin clearance contributes substantially to insulin sensitivity, and may be pivotal in understanding the pathogenesis of insulin resistance. We propose the hyperinsulinemia due to reduction in insulin clearance is responsible for insulin resistance secondary to changes in body weight.</description><identifier>ISSN: 1930-7381</identifier><identifier>EISSN: 1930-739X</identifier><identifier>DOI: 10.1002/oby.20625</identifier><identifier>PMID: 24123967</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Animals ; Blood Glucose - metabolism ; Body Composition ; Body Mass Index ; Body Weight ; Diabetes Mellitus, Type 2 - blood ; Dogs ; Fasting ; Glucose ; Glucose Clamp Technique - methods ; Hyperglycemia ; Hyperinsulinism ; Insulin ; Insulin - blood ; Insulin resistance ; Insulin Resistance - physiology ; Liver - metabolism ; Magnetic Resonance Imaging ; Male ; Obesity ; Obesity - blood ; Rodents</subject><ispartof>Obesity (Silver Spring, Md.), 2014-05, Vol.22 (5), p.1238-1245</ispartof><rights>Copyright © 2013 The Obesity Society</rights><rights>Copyright © 2013 The Obesity Society.</rights><rights>Copyright Blackwell Publishing Ltd. May 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4545-7e81ee58a23a42b044e94d7a8a065cb7f883f815f8b174a8d74fda27739f7f583</citedby><cites>FETCH-LOGICAL-c4545-7e81ee58a23a42b044e94d7a8a065cb7f883f815f8b174a8d74fda27739f7f583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Foby.20625$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Foby.20625$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,1435,27931,27932,45581,45582,46416,46840</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24123967$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ader, Marilyn</creatorcontrib><creatorcontrib>Stefanovski, Darko</creatorcontrib><creatorcontrib>Kim, Stella P.</creatorcontrib><creatorcontrib>Richey, Joyce M.</creatorcontrib><creatorcontrib>Ionut, Viorica</creatorcontrib><creatorcontrib>Catalano, Karyn J.</creatorcontrib><creatorcontrib>Hucking, Katrin</creatorcontrib><creatorcontrib>Ellmerer, Martin</creatorcontrib><creatorcontrib>Citters, Gregg</creatorcontrib><creatorcontrib>Hsu, Isabel R.</creatorcontrib><creatorcontrib>Chiu, Jenny D.</creatorcontrib><creatorcontrib>Woolcott, Orison O.</creatorcontrib><creatorcontrib>Harrison, Lisa N.</creatorcontrib><creatorcontrib>Zheng, Dan</creatorcontrib><creatorcontrib>Lottati, Maya</creatorcontrib><creatorcontrib>Kolka, Cathryn M.</creatorcontrib><creatorcontrib>Mooradian, Vahe</creatorcontrib><creatorcontrib>Dittmann, Justin</creatorcontrib><creatorcontrib>Yae, Sophia</creatorcontrib><creatorcontrib>Liu, Huiwen</creatorcontrib><creatorcontrib>Castro, Ana Valeria B.</creatorcontrib><creatorcontrib>Kabir, Morvarid</creatorcontrib><creatorcontrib>Bergman, Richard N.</creatorcontrib><title>Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog</title><title>Obesity (Silver Spring, Md.)</title><addtitle>Obesity (Silver Spring)</addtitle><description>Objective Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other than obesity are more substantial predictors of insulin sensitivity under baseline, nonstimulated conditions. Methods Metabolic assessment was performed in healthy dogs (n = 90). Whole‐body sensitivity from euglycemic clamps (SICLAMP) was the primary outcome variable, and was measured independently by IVGTT (n = 36). Adiposity was measured by MRI (n = 90), and glucose‐stimulated insulin response was measured from hyperglycemic clamp or IVGTT (n = 86 and 36, respectively). Results SICLAMP was highly variable (5.9‐75.9 dl/min per kg per μU/ml). Despite narrow range of body weight (mean, 28.7 ± 0.3 kg), adiposity varied approximately eight‐fold and was inversely correlated with SICLAMP (P &lt; 0.025). SICLAMP was negatively associated with fasting insulin, but most strongly associated with insulin clearance. Clearance was the dominant factor associated with sensitivity (r = 0.53, P &lt; 0.00001), whether calculated from clamp or IVGTT. Conclusions These data suggest that insulin clearance contributes substantially to insulin sensitivity, and may be pivotal in understanding the pathogenesis of insulin resistance. We propose the hyperinsulinemia due to reduction in insulin clearance is responsible for insulin resistance secondary to changes in body weight.</description><subject>Animals</subject><subject>Blood Glucose - metabolism</subject><subject>Body Composition</subject><subject>Body Mass Index</subject><subject>Body Weight</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Dogs</subject><subject>Fasting</subject><subject>Glucose</subject><subject>Glucose Clamp Technique - methods</subject><subject>Hyperglycemia</subject><subject>Hyperinsulinism</subject><subject>Insulin</subject><subject>Insulin - blood</subject><subject>Insulin resistance</subject><subject>Insulin Resistance - physiology</subject><subject>Liver - metabolism</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Obesity</subject><subject>Obesity - blood</subject><subject>Rodents</subject><issn>1930-7381</issn><issn>1930-739X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFLwzAUx4MoTqcHv4AUvOhhW5ImTXrUoU4Y7KKgBwlp-6IZbTqTVum3t25zB8HTezx-7897P4TOCB4TjOmkzroxxQnle-iIpDEeiTh93t_1kgzQcQhLjFmCOTlEA8oIjdNEHKHXGax0Y_PIutCW1kV5Cdprl0NkQ9S8Q7TyttK-iwpowFfWaddEtdnxAVywjf20TdfP1huu9pUuo6J-O0EHRpcBTrd1iJ7ubh-ns9F8cf8wvZ6PcsYZHwmQBIBLTWPNaIYZg5QVQkuNE55nwkgZG0m4kRkRTMtCMFNoKvo3jTBcxkN0ucld-fqjhdCoyoYcylI7qNugCKckjlNMWI9e_EGXdetdf50iieAkpbhnh-hqQ-W-DsGDUVsNimD141z1ztXaec-ebxPbrIJiR_5K7oHJBviyJXT_J6nFzcsm8huKdIr5</recordid><startdate>201405</startdate><enddate>201405</enddate><creator>Ader, Marilyn</creator><creator>Stefanovski, Darko</creator><creator>Kim, Stella P.</creator><creator>Richey, Joyce M.</creator><creator>Ionut, Viorica</creator><creator>Catalano, Karyn J.</creator><creator>Hucking, Katrin</creator><creator>Ellmerer, Martin</creator><creator>Citters, Gregg</creator><creator>Hsu, Isabel R.</creator><creator>Chiu, Jenny D.</creator><creator>Woolcott, Orison O.</creator><creator>Harrison, Lisa N.</creator><creator>Zheng, Dan</creator><creator>Lottati, Maya</creator><creator>Kolka, Cathryn M.</creator><creator>Mooradian, Vahe</creator><creator>Dittmann, Justin</creator><creator>Yae, Sophia</creator><creator>Liu, Huiwen</creator><creator>Castro, Ana Valeria B.</creator><creator>Kabir, Morvarid</creator><creator>Bergman, Richard N.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201405</creationdate><title>Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog</title><author>Ader, Marilyn ; Stefanovski, Darko ; Kim, Stella P. ; Richey, Joyce M. ; Ionut, Viorica ; Catalano, Karyn J. ; Hucking, Katrin ; Ellmerer, Martin ; Citters, Gregg ; Hsu, Isabel R. ; Chiu, Jenny D. ; Woolcott, Orison O. ; Harrison, Lisa N. ; Zheng, Dan ; Lottati, Maya ; Kolka, Cathryn M. ; Mooradian, Vahe ; Dittmann, Justin ; Yae, Sophia ; Liu, Huiwen ; Castro, Ana Valeria B. ; Kabir, Morvarid ; Bergman, Richard N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4545-7e81ee58a23a42b044e94d7a8a065cb7f883f815f8b174a8d74fda27739f7f583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Blood Glucose - metabolism</topic><topic>Body Composition</topic><topic>Body Mass Index</topic><topic>Body Weight</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Dogs</topic><topic>Fasting</topic><topic>Glucose</topic><topic>Glucose Clamp Technique - methods</topic><topic>Hyperglycemia</topic><topic>Hyperinsulinism</topic><topic>Insulin</topic><topic>Insulin - blood</topic><topic>Insulin resistance</topic><topic>Insulin Resistance - physiology</topic><topic>Liver - metabolism</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Obesity</topic><topic>Obesity - blood</topic><topic>Rodents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ader, Marilyn</creatorcontrib><creatorcontrib>Stefanovski, Darko</creatorcontrib><creatorcontrib>Kim, Stella P.</creatorcontrib><creatorcontrib>Richey, Joyce M.</creatorcontrib><creatorcontrib>Ionut, Viorica</creatorcontrib><creatorcontrib>Catalano, Karyn J.</creatorcontrib><creatorcontrib>Hucking, Katrin</creatorcontrib><creatorcontrib>Ellmerer, Martin</creatorcontrib><creatorcontrib>Citters, Gregg</creatorcontrib><creatorcontrib>Hsu, Isabel R.</creatorcontrib><creatorcontrib>Chiu, Jenny D.</creatorcontrib><creatorcontrib>Woolcott, Orison O.</creatorcontrib><creatorcontrib>Harrison, Lisa N.</creatorcontrib><creatorcontrib>Zheng, Dan</creatorcontrib><creatorcontrib>Lottati, Maya</creatorcontrib><creatorcontrib>Kolka, Cathryn M.</creatorcontrib><creatorcontrib>Mooradian, Vahe</creatorcontrib><creatorcontrib>Dittmann, Justin</creatorcontrib><creatorcontrib>Yae, Sophia</creatorcontrib><creatorcontrib>Liu, Huiwen</creatorcontrib><creatorcontrib>Castro, Ana Valeria B.</creatorcontrib><creatorcontrib>Kabir, Morvarid</creatorcontrib><creatorcontrib>Bergman, Richard N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity (Silver Spring, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ader, Marilyn</au><au>Stefanovski, Darko</au><au>Kim, Stella P.</au><au>Richey, Joyce M.</au><au>Ionut, Viorica</au><au>Catalano, Karyn J.</au><au>Hucking, Katrin</au><au>Ellmerer, Martin</au><au>Citters, Gregg</au><au>Hsu, Isabel R.</au><au>Chiu, Jenny D.</au><au>Woolcott, Orison O.</au><au>Harrison, Lisa N.</au><au>Zheng, Dan</au><au>Lottati, Maya</au><au>Kolka, Cathryn M.</au><au>Mooradian, Vahe</au><au>Dittmann, Justin</au><au>Yae, Sophia</au><au>Liu, Huiwen</au><au>Castro, Ana Valeria B.</au><au>Kabir, Morvarid</au><au>Bergman, Richard N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog</atitle><jtitle>Obesity (Silver Spring, Md.)</jtitle><addtitle>Obesity (Silver Spring)</addtitle><date>2014-05</date><risdate>2014</risdate><volume>22</volume><issue>5</issue><spage>1238</spage><epage>1245</epage><pages>1238-1245</pages><issn>1930-7381</issn><eissn>1930-739X</eissn><abstract>Objective Insulin resistance is a powerful risk factor for Type 2 diabetes and a constellation of chronic diseases, and is most commonly associated with obesity. We examined if factors other than obesity are more substantial predictors of insulin sensitivity under baseline, nonstimulated conditions. Methods Metabolic assessment was performed in healthy dogs (n = 90). Whole‐body sensitivity from euglycemic clamps (SICLAMP) was the primary outcome variable, and was measured independently by IVGTT (n = 36). Adiposity was measured by MRI (n = 90), and glucose‐stimulated insulin response was measured from hyperglycemic clamp or IVGTT (n = 86 and 36, respectively). Results SICLAMP was highly variable (5.9‐75.9 dl/min per kg per μU/ml). Despite narrow range of body weight (mean, 28.7 ± 0.3 kg), adiposity varied approximately eight‐fold and was inversely correlated with SICLAMP (P &lt; 0.025). SICLAMP was negatively associated with fasting insulin, but most strongly associated with insulin clearance. Clearance was the dominant factor associated with sensitivity (r = 0.53, P &lt; 0.00001), whether calculated from clamp or IVGTT. Conclusions These data suggest that insulin clearance contributes substantially to insulin sensitivity, and may be pivotal in understanding the pathogenesis of insulin resistance. We propose the hyperinsulinemia due to reduction in insulin clearance is responsible for insulin resistance secondary to changes in body weight.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>24123967</pmid><doi>10.1002/oby.20625</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1930-7381
ispartof Obesity (Silver Spring, Md.), 2014-05, Vol.22 (5), p.1238-1245
issn 1930-7381
1930-739X
language eng
recordid cdi_proquest_miscellaneous_1521339014
source MEDLINE; Wiley Free Content; Wiley Online Library All Journals
subjects Animals
Blood Glucose - metabolism
Body Composition
Body Mass Index
Body Weight
Diabetes Mellitus, Type 2 - blood
Dogs
Fasting
Glucose
Glucose Clamp Technique - methods
Hyperglycemia
Hyperinsulinism
Insulin
Insulin - blood
Insulin resistance
Insulin Resistance - physiology
Liver - metabolism
Magnetic Resonance Imaging
Male
Obesity
Obesity - blood
Rodents
title Hepatic insulin clearance is the primary determinant of insulin sensitivity in the normal dog
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T22%3A35%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatic%20insulin%20clearance%20is%20the%20primary%20determinant%20of%20insulin%20sensitivity%20in%20the%20normal%20dog&rft.jtitle=Obesity%20(Silver%20Spring,%20Md.)&rft.au=Ader,%20Marilyn&rft.date=2014-05&rft.volume=22&rft.issue=5&rft.spage=1238&rft.epage=1245&rft.pages=1238-1245&rft.issn=1930-7381&rft.eissn=1930-739X&rft_id=info:doi/10.1002/oby.20625&rft_dat=%3Cproquest_cross%3E1521339014%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1675192021&rft_id=info:pmid/24123967&rfr_iscdi=true